Consider a long-term value play in UnitedHealth Group (UNH), which is viewed as significantly undervalued and could reach $460 per share by late 2027. A specific options strategy to consider is the December 2027 call debit spread, buying the $420 call and selling the $460 call for defined risk exposure. With geopolitical risks subsiding, the "war premium" has been removed from crude oil, suggesting a bearish outlook for energy stocks in the near term. In the popular weight-loss drug sector, Eli Lilly (LLY) is reportedly gaining significant market share from competitor Novo Nordisk (NVO). Investors in Hims & Hers (HIMS) face a critical decision, as the stock's recent crash presents either a broken investment thesis or a potential high-risk buying opportunity.

Hims & Hers Health, Inc. (HIMS)

• The stock plummeted over 35% in a single day, marking its worst day in history.
• The primary cause was the termination of its partnership with pharmaceutical giant Novo Nordisk, the maker of the popular weight-loss drug Wegovy.
• Novo Nordisk publicly raised concerns about the "legality and safety" of HIMS selling what it called "knockoff versions" of their drug.
• HIMS CEO Andrew Dudum responded on social media, stating that Novo Nordisk was trying to "strong-arm" the company into exclusively promoting its products, which HIMS refused to do to maintain clinical independence and patient choice.
• The podcast highlights a sharp divide among investors:
  • Bear Case: Some investors see this as a "thesis breaker," arguing it exposes a lack of a durable competitive advantage (moat) if the loss of one partnership can cause such a massive drop. Concerns about upcoming lawsuits were also mentioned.
  • Bull Case / Overreaction: Others believe this is a "massive overreaction," arguing that this single partnership was not the core of the company's long-term value proposition.
• The host noted that short interest in HIMS reached an all-time high, with short-sellers capitalizing on the news.
• The host personally holds a position in HIMS and did not sell during the drop, viewing it as a moment to reassess belief in the long-term story rather than panic-selling.

Takeaways

• High Risk & Volatility: The stock is currently experiencing extreme volatility and negative sentiment following the Novo Nordisk news. The situation has created significant uncertainty.
• A Defining Moment: This is a critical event for the company. Investors must decide whether they believe the loss of this partnership fundamentally breaks the investment thesis or if it's a temporary setback and a potential buying opportunity.
• Watch Management's Response: The effectiveness of the company's response to Novo Nordisk's allegations and its strategy moving forward will be crucial for rebuilding investor trust. The host felt the CEO's initial response on Twitter lacked the substance of a formal press release.

UnitedHealth Group (UNH)

• The host initiated a new position in UNH via a long-term options strategy, viewing the stock as significantly undervalued.
• The Trade: A call debit spread was purchased with a December 2027 expiration.
  • Bought the $420 strike call
  • Sold the $460 strike call
  • This trade offers a potential ~5x return if UNH stock reaches $460 per share by the end of 2027.
• Bullish Rationale:
  • Valuation: The stock is trading at just 11 times free cash flow, which the host described as "insanity" for a company of its quality.
  • Durable Moat: A guest analyst described UNH as a "blue chip business" with a massive competitive advantage that is difficult to replicate, particularly highlighting its often-overlooked Optum business segment.
  • Insider & Employee Buying: The discussion noted recent insider buying and an employee stock purchase plan offering a 10% discount, suggesting confidence from those closest to the company.
• The stock has been beaten down significantly (mentioned as down 60% from highs at one point), and the host believes it may be near a bottom.

Takeaways

• Value Play: UNH is being presented as a value investment in a high-quality, blue-chip company that is currently out of favor due to negative headlines.
• Long-Term Horizon: The investment idea is framed with a multi-year timeline (2.5 years), suggesting patience is required. The specific options trade targets a 50% stock price increase over that period.
• Contrarian Bet: Buying UNH is a bet that the market is overreacting to short-term issues and that the company's strong fundamentals and cash flow will ultimately drive the stock higher.

Oil & Geopolitical Situation

• The primary driver of the market's intraday movement was the geopolitical situation between Iran, Israel, and the U.S.
• An Iranian missile attack on a U.S. airbase in Qatar was revealed to be a "symbolic" and "staged show" that was coordinated in advance with the U.S. and Qatar to avoid casualties.
• The market initially dipped on fears of escalation but rallied strongly once it became clear that the conflict was being de-escalated.
• As a direct result, crude oil prices plunged 7-8%, falling from $75 to below $69 per barrel. Fears of major supply disruptions, such as the closure of the Strait of Hormuz, have significantly subsided.
• A guest analyst argued that oil prices are unlikely to spike to $120 because of OPEC's spare production capacity, the potential for increased U.S. shale production above $85/barrel, and China's vested interest in keeping Middle Eastern oil flowing.

Takeaways

• Reduced Risk Premium: The de-escalation has removed a significant "war premium" from oil prices, which is bearish for oil in the short term.
• Market Resilience: The stock market showed its resilience, interpreting the de-escalation as a major positive and quickly erasing intraday losses. The S&P 500 recovered to trade back near the 6,000 level.
• Investment Impact: This is bearish for oil stocks and energy-related investments that had rallied on fears of war. For the broader market, lower oil prices are a positive as they help ease inflation concerns.

Tesla, Inc. (TSLA)

• TSLA had a very strong day, finishing up ~8% around $348.
• The positive momentum was attributed to the ongoing narrative around its RoboTaxi technology.
• After the market closed, news broke that the NHTSA (a U.S. federal safety agency) had contacted Tesla regarding "RoboTaxi issues seen in online videos."
• This news caused a small dip in the after-hours session, but the host dismissed it as a "nothing burger," suggesting that regulatory inquiries are a normal part of developing such a novel technology.

Takeaways

• RoboTaxi is the Key Driver: The investment thesis for TSLA is currently heavily tied to the market's optimism about the future of its autonomous driving and RoboTaxi network.
• Expect Headline Risk: As RoboTaxi development continues, investors should expect ongoing scrutiny and potential negative headlines from regulators and safety advocates. The market's reaction to such headlines will be a key indicator of sentiment.

Other Notable Mentions

HIMS Competitors & Related Stocks

• Novo Nordisk (NVO): The company that terminated the HIMS partnership. Its stock also fell ~5.5% on the day of the announcement. The podcast noted that Novo's weight-loss drugs are facing intense competition.
• Eli Lilly (LLY): Mentioned as a major competitor to Novo Nordisk. Its weight-loss drugs, Zepbound and Mounjaro, are reportedly gaining significant market share and seeing prescription numbers grow much faster than Novo's.
• Oscar Health (OSCR): Another telehealth stock that was down about 4.5%. The host considers it "undervalued" but noted its volatility and chose to invest in the more established UNH instead.

Tech & Growth Stocks

• Microsoft (MSFT): Hit a new all-time high of $485, showing continued strong performance.
• Google (GOOGL): Viewed positively after announcing it would cut its smart TV budget to "double down" on its core YouTube business, which is seen as having a strong competitive moat.
• Rocket Lab (RKLB) & AST SpaceMobile (ASTS): Both space stocks showed significant strength. RKLB was up 9% and ASTS closed above the key $50 level, driven by recent partnership news.
• Super Micro Computer (SMCI): Fell 10% after the company announced it was raising $2 billion through a convertible note, which can be dilutive to existing shareholders.
• Netflix (NFLX) & Spotify (SPOT): Both streaming giants hit new all-time highs, indicating strong bullish momentum in the sector.
• Venture Global (VG): This private company in the oil & gas transport sector was down ~10-14%. This was attributed to the removal of the "war premium" and significant profit-taking after the stock had run up over 100% in recent months. A guest analyst believes it is now trading back at a more reasonable "fair value."